Worth Seeing!
Ditch the lottery mentality, build a stock market empire - Learn how the winning investors win. Learn Now Learn Now
mw4me logo
Talk to Us | Subscribe | Advisory Services

Top Pharma Companies in India by Market Capitalisation - Identify Top Performing Pharmaceutical Sector Companies for Investment Today

Sensex 73885.60
617.3 (-0.83%)

Pharma Sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical stocks even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma stocks:
  • Long-term profitability – Pharma stocks can be attractive to long-term investors in spite of the volatility. The ever rising industry size and healthcare becoming a critical part of life, investors can make good returns if they invest at the right time.
  • Exponential growth – Being the evolving industry that it is, innovation, scientific breakthroughs, and technological advances can bring in exponential growth for many pharma stocks.
×
×
Filter

Top Pharma Companies in India as on May-2024

|
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
1
Abbott India Ltd.
55,456
(Mid Cap)
25,919.40
(-0.68%)
46.17
14.99
10.15
20.60
Unlock
2
Sanofi India Ltd.
19,811
(Small Cap)
8,430
(-2.00%)
36.06
18.28
0.57
9.48
Unlock
3
Astrazeneca Pharma India Ltd.
15,915
(Small Cap)
6,365
(-0.02%)
98.54
22.36
11.93
36.87
Unlock
4
Neuland Laboratories Ltd.
7,800
(Small Cap)
6,195.20
(1.90%)
26.04
6.11
17.70
56.85
Unlock
5
Dr. Reddys Laboratories Ltd.
1,00,086
(Large Cap)
5,876.70
(-2.05%)
17.94
3.54
11.55
36.08
Unlock
6
Apollo Hospitals Enterprise Ltd.
84,929
(Large Cap)
5,761
(-2.47%)
85.05
11.24
-1.90
34.75
Unlock
7
Alkem Laboratories Ltd.
62,952
(Mid Cap)
4,951.90
(-5.95%)
36.03
5.91
11.39
9.10
Unlock
8
Procter & Gamble Health Ltd.
7,956
(Small Cap)
4,784.95
(-0.17%)
37.18
9.33
11.99
36.80
Unlock
9
Pfizer Ltd.
21,137
(Small Cap)
4,556.05
(-1.39%)
38.34
5.88
4.26
11.01
Unlock
10
Divis Laboratories Ltd.
1,18,095
(Large Cap)
4,439
(-0.21%)
73.81
8.7
14.82
15.00
Unlock
11
Kovai Medical Center & Hospital Ltd.
4,622
(Small Cap)
4,142
(-1.94%)
29.23
5.54
11.48
15.15
Unlock
12
Torrent Pharmaceuticals Ltd.
91,893
(Large Cap)
2,663.55
(-1.90%)
55.49
13.4
10.09
20.94
Unlock
13
Dr. Lal Pathlabs Ltd.
22,133
(Small Cap)
2,634.35
(-0.64%)
57.58
11.65
11.55
11.64
Unlock
14
Glaxosmithkline Pharmaceuticals Ltd.
42,972
(Mid Cap)
2,593
(2.22%)
72.84
24.17
2.52
11.21
Unlock
15
Ajanta Pharma Ltd.
30,143
(Small Cap)
2,412.80
(0.79%)
36.93
8.45
11.98
4.54
Unlock
16
NGL Fine-Chem Ltd.
1,409
(Small Cap)
2,257.10
(-1.00%)
36.57
5.36
19.33
11.86
Unlock
17
Mankind Pharma Ltd.
84,248
(Large Cap)
2,098
(-0.23%)
46.2
8.75
15.71
13.53
Unlock
18
Metropolis Healthcare Ltd.
10,085
(Small Cap)
1,920.60
(-2.44%)
78.9
9.2
12.15
6.00
Unlock
19
Gland Pharma Ltd.
30,630
(Mid Cap)
1,857
(-0.14%)
29.36
3.41
17.42
19.02
Unlock
20
Krishna Institute of Medical Sciences Ltd
14,575
(Small Cap)
1,827
(0.32%)
61.93
7.81
12.50
0.00
Unlock
21
Poly Medicure Ltd.
17,590
(Small Cap)
1,778.45
(-2.97%)
69.88
12.06
16.00
20.25
Unlock
22
Hester Biosciences Ltd.
1,528
(Small Cap)
1,776.05
(-1.10%)
56.25
4.89
13.51
0.65
Unlock
23
JB Chemicals & Pharmaceuticals Ltd.
27,450
(Small Cap)
1,743.80
(-1.41%)
50.52
9.51
18.11
31.92
Unlock
24
Lupin Ltd.
72,999
(Mid Cap)
1,577
(-1.52%)
38.13
5.11
1.04
9.19
Unlock
25
Cipla Ltd.
1,20,556
(Large Cap)
1,474.40
(-1.25%)
29.25
4.51
8.47
14.67
Unlock
26
Sun Pharmaceutical Industries Ltd.
3,54,706
(Large Cap)
1,466
(-0.84%)
37.04
5.57
10.69
26.54
Unlock
27
Concord Biotech Ltd.
15,172
(Small Cap)
1,450
(-0.02%)
49.24
9.94
0.00
0.00
Unlock
28
RPG Life Sciences Ltd.
2,390
(Small Cap)
1,438
(-0.51%)
27.27
6.38
8.32
38.58
Unlock
29
Caplin Point Laboratories Ltd.
9,944
(Small Cap)
1,298.10
(-0.86%)
21.75
4.29
22.13
21.09
Unlock
30
Ipca Laboratories Ltd.
32,834
(Mid Cap)
1,249.65
(-3.44%)
61.9
5.18
12.58
17.37
Unlock
Prev 1

Want to pick best stocks Undervalued Pharma Stocks for High returns?

Check Now!
Screens:
AlphaCases All-Weather Stocks 5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Glaxosmithkline Phar
2,5932.22%
Neuland Laboratories
6,195.201.90%
Narayana Hrudayalay
1,169.201.85%
Tarsons Products
424.251.27%
Jupiter Life Line
1,168.601.17%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Marksans Pharma
147.40-12.96%
Medicamen Biotech
477-6.13%
SMS Pharmaceuticals
198.65-6.01%
Alkem Laboratories
4,951.90-5.95%
Wockhardt
537.05-5%
View More

News about Top Pharma Companies in India

Alkem Laboratories reports over 4-fold jump in Q4 consolidated net profit

Total consolidated income of the company increased by 1.77% at Rs 3023.99 crore for Q4FY24
30 May, 2024

Concord Biotech informs about disclosures

Concord Biotech has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for 1575773 Ontario INC.

The above information is a part of company’s filings submitted to BSE.
29 May, 2024

Alkem Laboratories - Quaterly Results

The Revenue for the quarter ended  March 2024 of Rs. 23653.70 millions grew by 5.69 % from Rs. 22379.90 millions.The company has announced a 27.54% increase in its profits to Rs . 3249.70  millions for the  quarter ended March 2024 compared to Rs. 2547.90 millions in the corresponding quarter in the previous year.OP of the company witnessed a marginal growth to 4913.10 millions from 4085.90 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 23653.70 22379.90 5.69 97477.20 90545.50 7.66 97477.20 90545.50 7.66
Other Income 837.90 766.00 9.39 3059.90 2662.90 14.91 3059.90 2662.90 14.91
PBIDT 4913.10 4085.90 20.25 22711.20 16432.40 38.21 22711.20 16432.40 38.21
Interest 206.80 217.40 -4.88 819.10 864.00 -5.20 819.10 864.00 -5.20
PBDT 4581.10 3868.50 18.42 21253.80 15568.40 36.52 21253.80 15568.40 36.52
Depreciation 691.00 571.60 20.89 2443.50 2298.50 6.31 2443.50 2298.50 6.31
PBT 3890.10 3296.90 17.99 18810.30 13269.90 41.75 18810.30 13269.90 41.75
TAX 640.40 749.00 -14.50 1338.80 1925.20 -30.46 1338.80 1925.20 -30.46
Deferred Tax -133.70 212.70 -162.86 -1994.00 -350.00 469.71 -1994.00 -350.00 469.71
PAT 3249.70 2547.90 27.54 17471.50 11344.70 54.01 17471.50 11344.70 54.01
Equity 239.10 239.10 0.00 239.10 239.10 0.00 239.10 239.10 0.00
PBIDTM(%) 20.77 18.26 13.77 23.30 18.15 28.38 23.30 18.15 28.38
29 May, 2024

Ipca Laboratories - Quaterly Results

The revenue for the March 2024 quarter is pegged at Rs. 15106.20 millions, about 7.78% up against Rs. 14016.30 millions recorded during the year-ago period.A slender decline of -23.65% was recorded to Rs. 647.60  millions from Rs. 848.20 millions in the corresponding previous quarter.Operating profit for the quarter ended March 2024 rose to 3074.40 millions as compared to 2091.10 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 15106.20 14016.30 7.78 61664.60 58146.20 6.05 61664.60 58146.20 6.05
Other Income 151.00 334.70 -54.88 1112.90 1111.90 0.09 1112.90 1111.90 0.09
PBIDT 3074.40 2091.10 47.02 13226.70 10230.40 29.29 13226.70 10230.40 29.29
Interest 240.60 176.90 36.01 1206.70 439.20 174.75 1206.70 439.20 174.75
PBDT 1890.60 1914.20 -1.23 10686.40 9791.20 9.14 10686.40 9791.20 9.14
Depreciation 617.60 592.10 4.31 2464.80 2286.30 7.81 2464.80 2286.30 7.81
PBT 1273.00 1322.10 -3.71 8221.60 7504.90 9.55 8221.60 7504.90 9.55
TAX 625.40 473.90 31.97 2917.50 2447.90 19.18 2917.50 2447.90 19.18
Deferred Tax 6.30 84.40 -92.54 37.40 208.40 -82.05 37.40 208.40 -82.05
PAT 647.60 848.20 -23.65 5304.10 5057.00 4.89 5304.10 5057.00 4.89
Equity 253.70 253.70 0.00 253.70 253.70 0.00 253.70 253.70 0.00
PBIDTM(%) 20.35 14.92 36.42 21.45 17.59 21.91 21.45 17.59 21.91
29 May, 2024

Apollo Hospitals Enterprise informs about loss of share certificate

Apollo Hospitals Enterprise has informed that the Company has received intimation from shareholder on May 29, 2024 regarding loss of share certificate. ln accordance with Regulation 39(3) of the Regulations, the details of the said share certificate are enclosed.

The above information is a part of company’s filings submitted to BSE.

29 May, 2024

NGL Fine-Chem informs about revised investor presentation

Pursuant to Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, NGL Fine-Chem has informed that it enclosed Revised Investor Presentation for the quarter and year ended March 31, 2024. The earlier Investor Presentation had some errors in financials which are now been rectified.

The above information is a part of company’s filings submitted to BSE.

28 May, 2024

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2024.
Rank Company Market Capitalization 2024 (INR  crores)
1 Abbott India Ltd. 55,456 Crore
2 Sanofi India Ltd. 19,811 Crore
3 Astrazeneca Pharma India Ltd. 15,915 Crore
4 Neuland Laboratories Ltd. 7,800 Crore
5 Dr. Reddys Laboratories Ltd. 1,00,086 Crore
6 Apollo Hospitals Enterprise Ltd. 84,929 Crore
7 Alkem Laboratories Ltd. 62,952 Crore
8 Procter & Gamble Health Ltd. 7,956 Crore
9 Pfizer Ltd. 21,137 Crore
10 Divis Laboratories Ltd. 1,18,095 Crore
Find best pharma stocks to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best stocks to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 8,430 19,811 36.06 18.28 23.13 51.69
Abbott India Ltd. (M) Very Good 25,919 55,456 46.17 14.99 31.34 31.69
Laurus Labs Ltd. (S) Very Good 429.4 23,730 147.8 5.77 32.46 21.71
Dr. Reddys Laboratories Ltd. (L) Very Good 5,877 1,00,086 17.94 3.54 11.33 20.88
Torrent Pharmaceuticals Ltd. (L) Very Good 2,664 91,893 55.49 13.40 27.73 20.23

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Zydus Lifesciences Ltd. (L) Very Good 1,025 1,05,162 104.1
Gland Pharma Ltd. (M) Very Good 1,857 30,630 104.0
Aurobindo Pharma Ltd. (M) Very Good 1,207 71,385 99.33
Lupin Ltd. (M) Somewhat Good 1,577 72,999 98.81
Glenmark Pharmaceuticals Ltd. (S) Somewhat Good 1,157 33,287 98.60
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Laurus Labs Ltd. (S) Very Good 429.4 23,730 147.8 5.77 32.46 24.05
Granules India Ltd. (S) Somewhat Good 424.1 10,415 23.89 3.35 13.93 19.01
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,744 27,450 50.52 9.51 30.33 18.11
Gland Pharma Ltd. (M) Very Good 1,857 30,630 29.36 3.41 18.43 17.42
Mankind Pharma Ltd. (L) Very Good 2,098 84,248 46.20 8.75 32.21 15.71

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Laurus Labs Ltd. (S) Very Good 429.4 23,730 147.8 5.77 32.46 38.61
Dr. Reddys Laboratories Ltd. (L) Very Good 5,877 1,00,086 17.94 3.54 11.33 36.08
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,744 27,450 50.52 9.51 30.33 31.92
Biocon Ltd. (M) Somewhat Good 310.8 38,851 325.7 3.56 88.45 31.80
Granules India Ltd. (S) Somewhat Good 424.1 10,415 23.89 3.35 13.93 31.51
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.